As of 2025-05-20, the Intrinsic Value of KOBO Biotech Ltd (531541.BO) is -48.90 INR. This 531541.BO valuation is based on the model Peter Lynch Fair Value. With the current market price of 2.72 INR, the upside of KOBO Biotech Ltd is -1,897.78%.
Based on its market price of 2.72 INR and our intrinsic valuation, KOBO Biotech Ltd (531541.BO) is overvalued by 1,897.78%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -48.90 - -48.90 | -48.90 | -1,897.78% |
| P/E | (37.00) - (42.38) | (37.09) | -1463.6% |
| DDM - Stable | (1.54) - (2.74) | (2.14) | -178.7% |
| DDM - Multi | (0.50) - (0.79) | (0.62) | -122.6% |
| Market Cap (mil) | 64.79 |
| Beta | 0.49 |
| Outstanding shares (mil) | 23.82 |
| Enterprise Value (mil) | 1,460.32 |
| Market risk premium | 8.31% |
| Cost of Equity | 85.02% |
| Cost of Debt | 5.00% |
| WACC | 7.10% |